ArticleOpen forum infectious diseases2022

Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance.

Rosa De Miguel Buckley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.